Knowledge Distillery

A significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this…

The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India. It has since then become dominant in some indian regions and UK and further…

The emergence of highly transmissible SARS-CoV-2 variants of concern (VOC) that are resistant to therapeutic antibodies highlights the need for…

Whilst respiratory failure in COVID-19 arises from severe interstitial lung involvement, SARS-CoV-2 likely spreads also through the nervous system.

Continued uncontrolled transmission of the SARS-CoV-2 in many parts of the world is creating the conditions for significant virus evolution.

The objective of this prospective uncontrolled cohort study was to describe the consequences at 4 months in patients hospitalized for COVID-19.

Extensive global sampling and sequencing of the pandemic virus SARS-CoV-2 have enabled researchers to monitor its spread, and to identify concerning…

SARS-CoV-2 infections and hospital admissions for COVID-19 increased rapidly in the South East region of England in November and December 2020,…

Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome,…

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…

The aim of this retrospective, international multicenter study was to assess the association between abnormal findings on chest and brain imaging in…

There is evidence of central nervous system impairments associated with COVID-19 infection, including encephalopathy.